Patient selection in non-small cell lung cancer: Histologic versus molecular subtypes?

Por Li, Tianhong
Publicado em 2010

Spatial disparity dynamics of ecosystem service values and GDP in Shaanxi Province, China in the last 30 years

Por Li, Tianhong, Ding, Yao
Publicado no PLoS One (2017)

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Por Ma, Weijie, Gilligan, Barbara M., Yuan, Jianda, Li, Tianhong
Publicado no J Hematol Oncol (2016)

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies

Por Li, Tianhong, Kung, Hsing-Jien, Mack, Philip C., Gandara, David R.
Publicado em 2013

Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts

Por Pohl, Nicole M., Tong, Chang, Fang, Wenfeng, Bi, Xiuli, Li, Tianhong, Yang, Wancai
Publicado em 2009

Genome-wide analysis of the GH3 family in apple (Malus × domestica)

Por Yuan, Huazhao, Zhao, Kai, Lei, Hengjiu, Shen, Xinjie, Liu, Yun, Liao, Xiong, Li, Tianhong
Publicado em 2013

CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation

Por Hong, Shiao-Ya, Shih, Yi-Ping, Li, Tianhong, Carraway, Kermit L., Lo, Su Hao
Publicado em 2013

The Cloning and Functional Characterization of Peach CONSTANS and FLOWERING LOCUS T Homologous Genes PpCO and PpFT

Por Zhang, Xiang, An, Lijun, Nguyen, Thi Hung, Liang, Huike, Wang, Rui, Liu, Xiayan, Li, Tianhong, Qi, Yafei, Yu, Fei
Publicado no PLoS One (2015)

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast canc...

Por Li, Tianhong, Guo, Mengye, Gradishar, William J., Sparano, Joseph A., Perez, Edith A., Wang, Molin, Sledge, George W.
Publicado no Breast Cancer Res Treat (2012)

KETCH1 imports HYL1 to nucleus for miRNA biogenesis in Arabidopsis

Por Zhang, Zhonghui, Guo, Xinwei, Ge, Chunxiao, Ma, Zeyang, Jiang, Mengqiu, Li, Tianhong, Koiwa, Hisashi, Yang, Seong Wook, Zhang, Xiuren
Publicado no Proc Natl Acad Sci U S A (2017)

Caveolin-1 Mutations in Human Breast Cancer : Functional Association with Estrogen Receptor α-Positive Status

Por Li, Tianhong, Sotgia, Federica, Vuolo, Magalis A., Li, Maomi, Yang, Wan Cai, Pestell, Richard G., Sparano, Joseph A., Lisanti, Michael P.
Publicado em 2006

Algorithm for Codevelopment of New Drug-Predictive Biomarker Combinations: Accounting for Inter- and Intrapatient Tumor Heterogeneity

Por Gandara, David R., Li, Tianhong, Lara, Primo N., Mack, Philip C., Kelly, Karen, Miyamoto, Suzanne, Goodwin, Neal, Beckett, Laurel, Redman, Mary W.
Publicado em 2012

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

Por Li, Tianhong, Christensen, Scott D., Frankel, Paul H., Margolin, Kim A., Agarwala, Sanjiv S., Luu, Thehang, Mack, Philip C., Lara, Primo N., Gandara, David R.
Publicado em 2010

First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advance...

Por Li, Tianhong, LoRusso, Patricia, Maitland, Michael L., Ou, Sai-Hong Ignatius, Bahceci, Erkut, Ball, Howard A., Park, Jung Wook, Yuen, Geoffrey, Tolcher, Anthony
Publicado no J Hematol Oncol (2016)

Lateral transport of soil carbon and land−atmosphere CO(2) flux induced by water erosion in China

Por Yue, Yao, Ni, Jinren, Ciais, Philippe, Piao, Shilong, Wang, Tao, Huang, Mengtian, Borthwick, Alistair G. L., Li, Tianhong, Wang, Yichu, Chappell, Adrian, Van Oost, Kristof
Publicado no Proc Natl Acad Sci U S A (2016)

Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

Por Sangha, Randeep, Davies, Angela M., Lara, Primo N., Mack, Philip C., Beckett, Laurel A., Hesketh, Paul J., Lau, Derick, Li, Tianhong, Perkins, Natasha, Gandara, David R.
Publicado em 2011

Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report

Por Li, Hong, Ma, Weijie, Yoneda, Ken Y., Moore, Elizabeth H., Zhang, Yanhong, Pu, Lee L. Q., Frampton, Garrett M., Molmen, Michael, Stephens, Philip J., Li, Tianhong
Publicado no J Hematol Oncol (2017)

Phase II Study of the AKT inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer who Previously Progressed on Erlotinib

Por Lara, Primo N., Longmate, Jeff, Mack, Philip C., Kelly, Karen, Socinski, Mark A., Salgia, Ravi, Gitlitz, Barbara, Li, Tianhong, Koczywas, Mariana, Reckamp, Karen L., Gandara, David R.
Publicado no Clin Cancer Res (2015)

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors

Por Xiao, Wenwu, Li, Tianhong, Bononi, Fernanda C., Lac, Diana, Kekessie, Ivy A., Liu, Yanlei, Sanchez, Eduardo, Mazloom, Anisha, Ma, Ai-hong, Lin, Jia, Tran, Jimmy, Yang, Kevin, Lam, Kit S., Liu, Ruiwu
Publicado no EJNMMI Res (2016)

Phase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors

Por Tomlinson, Benjamin K., Thomson, James A., Bomalaski, John S., Diaz, Monica, Akande, Taiwo, Mahaffey, Nichole, Li, Tianhong, Dutia, Mrinal P., Kelly, Karen, Gong, I-Yeh, Semrad, Thomas, Gandara, David R., Pan, Chong-Xian, Lara, Primo N.
Publicado no Clin Cancer Res (2015)